Status:
COMPLETED
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
Lead Sponsor:
Central South University
Collaborating Sponsors:
Xiangya Hospital of Central South University
Shanghai Mental Health Center
Conditions:
Schizophrenia
Metabolic Syndrome
Eligibility:
All Genders
17-65 years
Brief Summary
The study is performed in 20 different hospitals from 19 cities in China. Three sub-projects are included. About sub-project 1, we build a clinical database system and a biological sample bank for dat...
Detailed Description
For sub-project1 and 2:Inclusion criteria: Participants are ineligible to enter the trial under the following conditions: 1) Participants must be aged 18 to 65 years old who meet the criteria for schi...
Eligibility Criteria
Inclusion
- Meet the Diagnostic and Statistical Manual (DSM-V) diagnostic criteria for schizophrenia;
- Duration of illness less than 3 years with current symptoms exacerbation;
- Male and female with aged 17 to 65 years;
- Signed the study consent for participation
Exclusion
- Having history of substance dependence or abuse or whose symptoms are caused by the other diagnosable mental disorders;
- Having history of traumatic brain injury, seizures or other known neurological or organic diseases of the central nervous system;
- Taking antidepressants, stimulants, mood stabilizer or accepts electricity shock treatment;
- Having current suicidal or homicidal thoughts or any safety concern by research staff that cannot be manage in an inpatient setting;
- The routine blood tests showing abnormal renal, liver function;
- Pregnant or lactating women.
- No administration of any antibiotics in a mouth
Key Trial Info
Start Date :
January 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03451734
Start Date
January 23 2018
End Date
June 30 2021
Last Update
August 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mental Health Institute of 2nd Xiangya Hospital,CSU
Changsha, Hunan, China, 410011